focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntertek Group Regulatory News (ITRK)

Share Price Information for Intertek Group (ITRK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,904.00
Bid: 4,914.00
Ask: 4,916.00
Change: -18.00 (-0.37%)
Spread: 2.00 (0.041%)
Open: 4,904.00
High: 4,972.00
Low: 4,904.00
Prev. Close: 4,922.00
ITRK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Intertek Acquires Ageus Solutions

22 Oct 2007 16:37

Intertek Group plc (Intertek), a leading international provider ofquality and safety services to a wide range of industries, announcedthat its Restricted Substances Consulting Services Group has acquiredAgeus Solutions. £ Ageus Solutions provides global environmental complianceconsulting, technology services, and product stewardship to theelectronics and other industries. Ageus helps clients facilitatecorporate and product compliance with the myriad of global regulationsrelated to the environment. £ Ageus Solutions is one of the leading global REACH, EU RoHS, EUWEEE, China RoHS, and Japan Green service providers. Since itsinception in 2004, Ageus Solutions has assisted over 150 companiescomplete RoHS conversion of thousands of products ranging from musicalinstruments to telecommunications devices to medical devices. £ Executive Vice President Intertek, Mark Loughead, said, "AgeusSolutions significantly expands and compliments existing Intertekexpertise and value-added services in areas such as REACH and RoHS.Our customers will greatly benefit from the addition of AgeusSolutions to our offering, on a global basis." £ Ageus Solutions President and Chief Executive Officer, BruceCalder, said, "Becoming part of the global Intertek network allowsAgeus Solutions to reach many new potential clients. Ageus Solutions'core strength lies in taking regulatory knowledge and applying it to acompany's specific products and processes. Ageus Solutions understandsglobal environmental legislation from a macro-level to a micro-levelto facilitate accurate interpretation of client obligations andeffective implementation into their supply chains." £ Intertek and Ageus Solutions provide comprehensive REACH servicesto clients including on-call consulting services integrated to alllevels and sizes of business. With the on-call consulting service,clients gain access to unlimited REACH support with Ageus Solutions'REACH experts. Combined with Ageus Solutions' expertise, Intertek cannow effectively manage client's REACH strategy, ensure their REACHrequirements are properly applied and met, and educate employees onREACH policy. £ About Ageus Solutions: £ Ageus Solutions provides a comprehensive approach to compliancewith e-waste requirements including product conversion, materialdeclaration, government reporting, and due diligence documentation.Ageus Solutions has implemented environmental compliance solutions forhundreds of manufacturers and distributors from across the globeincluding Europe, the US, Canada, Mexico, Australia, New Zealand,Israel, Taiwan, and China. Ageus Solutions was ranked 13th in ProfitMagazine's 8th Annual Hot 50, a ranking of Canada's Emerging GrowthCompanies for 2007. £ About Intertek: £ Intertek is a leading international provider of quality and safetyservices to a wide range of global and local industries. Partnershipwith Intertek brings increased value to customers' products andprocesses, ultimately supporting their success in the global marketplace. Intertek is listed on the London Stock Exchange (LSE:ITRK). Forfurther information, visit www.intertek.com. £ Intertek REACH and Restricted Substances services are offered toclients across industries on a global basis. Visithttp://www.intertek-cb.com/reach/index.shtml for REACH services andwww.intertek-rohs.com to learn more. Copyright Business Wire 2007
Date   Source Headline
22nd Mar 20249:00 amRNSAnnual Financial Report
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
14th Mar 20241:00 pmRNSDirector/PDMR Shareholding
13th Mar 20241:00 pmRNSDirector/PDMR Shareholding
5th Mar 20247:00 amRNSFinal Results
4th Mar 20247:00 amRNSAcquisition
1st Mar 20241:00 pmRNSDirectorate Change
28th Feb 20241:00 pmRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSTrading Statement
22nd Nov 20231:00 pmRNSBlock listing Interim Review
14th Sep 20231:00 pmRNSDirector Declaration
24th Aug 20237:00 amRNSAcquisition
28th Jul 20237:00 amRNSHalf-year Report
12th Jul 202310:00 amRNSDirectorate Change
7th Jun 20231:00 pmRNSDirector/PDMR Shareholding
31st May 20231:00 pmRNSDirector/PDMR Shareholding
30th May 20233:00 pmRNSHolding(s) in Company
30th May 20231:00 pmRNSBlock listing Interim Review
24th May 202311:00 amRNSResult of AGM
24th May 20237:00 amRNSTrading Statement
3rd May 20237:00 amRNSCapital Markets Event
27th Apr 20234:00 pmRNSDirector Declaration
26th Apr 20234:30 pmRNSDirector Declaration
20th Apr 20234:00 pmRNSDirector Declaration
3rd Apr 20237:00 amRNSAcquisition
24th Mar 20239:00 amRNSNotice of 2023 AGM
21st Mar 20239:00 amRNSAnnual Financial Report
20th Mar 20237:00 amRNSDirectorate Change
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
14th Mar 20233:00 pmRNSDirector/PDMR Shareholding
28th Feb 20237:00 amRNSFinal Results
23rd Dec 202210:00 amRNSDirectorate Change
13th Dec 202211:00 amRNSDirector Declaration
12th Dec 20221:00 pmRNSDirector Declaration
24th Nov 20227:00 amRNSTrading Statement
21st Nov 20221:00 pmRNSBlock listing Interim Review
2nd Aug 20229:00 amRNSDirector/PDMR Shareholding
29th Jul 20227:01 amRNSAcquisition
29th Jul 20227:00 amRNSHalf-year Report
21st Jun 20221:00 pmRNSDirector/PDMR Shareholding
26th May 20227:00 amRNSDirectorate Change
25th May 202211:00 amRNSResult of AGM
25th May 20227:00 amRNSTrading Statement
23rd May 20221:00 pmRNSBlock listing Interim Review
4th Apr 20223:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20221:00 pmRNSDirector/PDMR Shareholding
18th Mar 20229:00 amRNSAnnual Financial Report
14th Mar 20221:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.